If you’ve been diagnosed with obstructive sleep apnea (OSA), you’ve probably received a prescription for continuous positive airway pressure (CPAP) therapy. “Continuous positive airway pressure is ...

Welcome to Sleep Better Week on the Strategist, where we’re helping you find everything you need to get your best rest — from testing the most comfortable mattresses to asking nosy questions about ...

CPAP machines are gaining popularity due to increased public discussion and awareness of sleep apnea. Affordable at-home sleep tests are now available, making diagnosis more accessible than ...

At-home sleep tests offer a convenient way to diagnose sleep apnea without visiting a lab. CPAP machines are a highly effective, life-changing treatment for those with sleep apnea. Modern CPAP ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ResMed has been growing, and investing in further growth as well -- especially via digital technologies. Its stock is appealingly priced at recent levels. It's worth a closer look. First, a little ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Getting diagnosed with severe obstructive sleep apnea ...

GREENWOOD, Ind. — Officials with the Indiana Office of Commerce and the office of Indiana Gov. Mike Braun announced on Tuesday that a new company centered on health technology will establish its first ...

Jan 29 (Reuters) - Medical device maker ResMed (RMD.N), opens new tab on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep ...

Sandercock provided updated guidance: "Looking forward and subject to currency movements, we now expect gross margin will be in the range of 62% to 63% for fiscal year 2026." SG&A expenses as a ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.